Native aortic valve Staphylococcus warneri endocarditis after COVID-19 infection: a case report and a review of literature
- PMID: 35218080
- PMCID: PMC9111267
- DOI: 10.1111/apm.13217
Native aortic valve Staphylococcus warneri endocarditis after COVID-19 infection: a case report and a review of literature
Abstract
We report a case of Staphylococcus warneri native valve endocarditis in an immunocompetent healthy adult, without known risk factors for infective endocarditis, two months following COVID-19 infection, who recovered with conservative treatment. Additionally, we reviewed previous cases of native valve endocarditis caused by Staphylococcus warneri and summarized the main clinical implications.
Keywords: COVID-19; Native valve endocarditis; coagulase-negative staphylococcal infection.
© 2022 Scandinavian Societies for Medical Microbiology and Pathology.
Conflict of interest statement
The authors have no conflicts of interest to declare.
Figures
References
-
- Chambers HF, Bayer AS. Native‐valve infective endocarditis. N. Engl. J. Med. 2020;383:567–76. - PubMed
-
- Hassidim A, Elinav H, Michael‐Gayego A, Benenson S, Yaalomy S, Meir K, et al. Breast implant Q fever as a source of in‐hospital transmission. Clin Infect Dis. 2018;66:793–5. - PubMed
-
- CLSI . Performance standards for antimicrobial susceptibility testing, 30th edn (supplement M100). Clinical and Laboratory Standards Institute; 2020: 1–332.
Publication types
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
